About The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy
During the past decade, The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy
According to Clinical.Site data, the most researched conditions in "The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy" are
"Multiple Myeloma" (1 trials), "Neoplasms" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Triple-negative Breast Cancer" (1 trials). Many other conditions were trialed in "The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy" in a lesser frequency.
Clinical Trials Intervention Types at The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy
Most popular intervention types in "The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "5-FU" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Cetuximab" (1 trials) and "Encorafenib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy
The vast majority of trials in "The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy" are
3 trials for "All" genders.
Clinical Trials Status at The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy
Currently, there are NaN active trials in "The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy, 2 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".